Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006

Abstract Background Lymphatic filariasis (LF) occurs when filarial parasites are transmitted to humans through mosquitoes. The filarial worms affect the lymphatic system which leads to abnormal enlargement of body parts, chronic pain, disability, and social discrimination. In 1999, a commitment was...

Full description

Bibliographic Details
Published in:Tropical Medicine and Health
Main Authors: Tammy Allen, Fasihah Taleo, Patricia M. Graves, Peter Wood, George Taleo, Margaret C. Baker, Mark Bradley, Kazuyo Ichimori
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2017
Subjects:
Online Access:https://doi.org/10.1186/s41182-017-0047-8
https://doaj.org/article/eb6080c14b4943359baec1a352f8f7fd
id ftdoajarticles:oai:doaj.org/article:eb6080c14b4943359baec1a352f8f7fd
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:eb6080c14b4943359baec1a352f8f7fd 2023-05-15T15:11:11+02:00 Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006 Tammy Allen Fasihah Taleo Patricia M. Graves Peter Wood George Taleo Margaret C. Baker Mark Bradley Kazuyo Ichimori 2017-06-01T00:00:00Z https://doi.org/10.1186/s41182-017-0047-8 https://doaj.org/article/eb6080c14b4943359baec1a352f8f7fd EN eng BMC http://link.springer.com/article/10.1186/s41182-017-0047-8 https://doaj.org/toc/1349-4147 doi:10.1186/s41182-017-0047-8 1349-4147 https://doaj.org/article/eb6080c14b4943359baec1a352f8f7fd Tropical Medicine and Health, Vol 45, Iss 1, Pp 1-11 (2017) Vanuatu Lymphatic filariasis PacELF Elimination Mass drug administration Arctic medicine. Tropical medicine RC955-962 article 2017 ftdoajarticles https://doi.org/10.1186/s41182-017-0047-8 2022-12-31T14:08:57Z Abstract Background Lymphatic filariasis (LF) occurs when filarial parasites are transmitted to humans through mosquitoes. The filarial worms affect the lymphatic system which leads to abnormal enlargement of body parts, chronic pain, disability, and social discrimination. In 1999, a commitment was made to eliminate LF from the Pacific Region by 2010. The Pacific Program to Eliminate LF began, with Vanuatu being one of the 16 endemic countries included in this program. Methods In 1997/1998 a LF prevalence baseline survey was conducted to determine the need for mass drug administration (MDA) in Vanuatu. In 1999, the Vanuatu Lymphatic Filariasis Control Program was established, and nationwide MDA was implemented from 2000 to 2004. LF prevalence was collected during the MDA through sentinel site and spot check surveys, and after 5 years of MDA. MDA implementation methods included health worker training, social mobilization, and culturally appropriate health promotion strategies. Results LF prevalence at baseline was 4.79%; after MDA this declined to 0.16% in 2005/2006. Average MDA coverage ranged from 75.5–81.5% across 5 years. All three evaluation units surveyed in 2005/2006 were below the 1% threshold required to stop MDA. Conclusions The LF Control Program between 1997 and 2006 was successful in reducing LF prevalence to <1%. High MDA coverage was a critical component of this success. This period of the Vanuatu LF Control Program played an important role in helping to eliminate LF in Vanuatu. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Pacific Tropical Medicine and Health 45 1
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Vanuatu
Lymphatic filariasis
PacELF
Elimination
Mass drug administration
Arctic medicine. Tropical medicine
RC955-962
spellingShingle Vanuatu
Lymphatic filariasis
PacELF
Elimination
Mass drug administration
Arctic medicine. Tropical medicine
RC955-962
Tammy Allen
Fasihah Taleo
Patricia M. Graves
Peter Wood
George Taleo
Margaret C. Baker
Mark Bradley
Kazuyo Ichimori
Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
topic_facet Vanuatu
Lymphatic filariasis
PacELF
Elimination
Mass drug administration
Arctic medicine. Tropical medicine
RC955-962
description Abstract Background Lymphatic filariasis (LF) occurs when filarial parasites are transmitted to humans through mosquitoes. The filarial worms affect the lymphatic system which leads to abnormal enlargement of body parts, chronic pain, disability, and social discrimination. In 1999, a commitment was made to eliminate LF from the Pacific Region by 2010. The Pacific Program to Eliminate LF began, with Vanuatu being one of the 16 endemic countries included in this program. Methods In 1997/1998 a LF prevalence baseline survey was conducted to determine the need for mass drug administration (MDA) in Vanuatu. In 1999, the Vanuatu Lymphatic Filariasis Control Program was established, and nationwide MDA was implemented from 2000 to 2004. LF prevalence was collected during the MDA through sentinel site and spot check surveys, and after 5 years of MDA. MDA implementation methods included health worker training, social mobilization, and culturally appropriate health promotion strategies. Results LF prevalence at baseline was 4.79%; after MDA this declined to 0.16% in 2005/2006. Average MDA coverage ranged from 75.5–81.5% across 5 years. All three evaluation units surveyed in 2005/2006 were below the 1% threshold required to stop MDA. Conclusions The LF Control Program between 1997 and 2006 was successful in reducing LF prevalence to <1%. High MDA coverage was a critical component of this success. This period of the Vanuatu LF Control Program played an important role in helping to eliminate LF in Vanuatu.
format Article in Journal/Newspaper
author Tammy Allen
Fasihah Taleo
Patricia M. Graves
Peter Wood
George Taleo
Margaret C. Baker
Mark Bradley
Kazuyo Ichimori
author_facet Tammy Allen
Fasihah Taleo
Patricia M. Graves
Peter Wood
George Taleo
Margaret C. Baker
Mark Bradley
Kazuyo Ichimori
author_sort Tammy Allen
title Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
title_short Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
title_full Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
title_fullStr Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
title_full_unstemmed Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
title_sort impact of the lymphatic filariasis control program towards elimination of filariasis in vanuatu, 1997–2006
publisher BMC
publishDate 2017
url https://doi.org/10.1186/s41182-017-0047-8
https://doaj.org/article/eb6080c14b4943359baec1a352f8f7fd
geographic Arctic
Pacific
geographic_facet Arctic
Pacific
genre Arctic
genre_facet Arctic
op_source Tropical Medicine and Health, Vol 45, Iss 1, Pp 1-11 (2017)
op_relation http://link.springer.com/article/10.1186/s41182-017-0047-8
https://doaj.org/toc/1349-4147
doi:10.1186/s41182-017-0047-8
1349-4147
https://doaj.org/article/eb6080c14b4943359baec1a352f8f7fd
op_doi https://doi.org/10.1186/s41182-017-0047-8
container_title Tropical Medicine and Health
container_volume 45
container_issue 1
_version_ 1766342083754328064